AN2 Therapeutics (ANTX)

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	33.50 mm	33.50 mm	33.50 mm	33.50 mm	33.50 mm	33.50 mm
Cash burn (monthly)	(no burn)	609.00 k	4.67 mm	5.78 mm	(no burn)	3.68 mm
Cash used (since last report)	n/a	1.70 mm	13.04 mm	16.13 mm	n/a	10.29 mm
Cash remaining	n/a	31.80 mm	20.46 mm	17.38 mm	n/a	23.21 mm
Runway (months of cash)	n/a	52.2	4.4	3.0	n/a	6.3

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q2 2024

ANTX institutional ownership history Ownership history

91.4% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	50	44	+13.6%
Opened positions	16	34	-52.9%
Closed positions	10	2	+400.0%
Increased positions	9	1	+800.0%
Reduced positions	10	2	+400.0%

13F shares	Current	Prev Q	Change
Total value	41.56 bn	41.55 bn	+0.0%
Total shares	27.28 mm	20.88 mm	+30.7%
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
Ra Capital Management	5.55 mm	$11.94 bn	0.0%
Octagon Capital Advisors	3.22 mm	$6.92 bn	NEW
Adjuvant Global Health Technology Fund	2.60 mm	$0.00	0.0%
Frazier Life Sciences Management	2.09 mm	$4.49 bn	+50.4%
Biotechnology Value Fund L P	1.56 mm	$0.00	0.0%
TCG Crossover Management	1.56 mm	$3.34 bn	0.0%
Citadel Advisors	1.55 mm	$3.34 bn	NEW
PFE Pfizer	1.36 mm	$0.00	0.0%
TCG Crossover GP I	1.29 mm	$10.02 mm	0.0%
JHG Janus Henderson	1.22 mm	$2.61 bn	NEW

Largest transactions	Shares	Bought/sold	Change
Octagon Capital Advisors	3.22 mm	+3.22 mm	NEW
Citadel Advisors	1.55 mm	+1.55 mm	NEW
JHG Janus Henderson	1.22 mm	+1.22 mm	NEW
Avidity Partners Management	0.00	-1.15 mm	EXIT
Frazier Life Sciences Management	2.09 mm	+700.00 k	+50.4%
Millennium Management	526.35 k	+526.35 k	NEW
GS The Goldman Sachs Group, Inc.	224.19 k	+195.82 k	+690.2%
Susquehanna International	31.25 k	-171.61 k	-84.6%
Two Sigma Advisers	134.70 k	+134.70 k	NEW
Alyeska Investment	100.00 k	+100.00 k	NEW

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

ANTX insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
10 Dec 24	Robin Shane Readnour	Common Stock	Buy	Acquire P	Yes	No	1.4935	5,000	7.47 k	652,573
10 Dec 24	Robin Shane Readnour	Common Stock	Buy	Acquire P	Yes	No	1.4924	5,000	7.46 k	582,288
9 Dec 24	Robin Shane Readnour	Common Stock	Buy	Acquire P	Yes	No	1.4287	18,483	26.41 k	647,573
9 Dec 24	Robin Shane Readnour	Common Stock	Buy	Acquire P	Yes	No	1.4303	12,289	17.58 k	577,288
6 Dec 24	Robin Shane Readnour	Common Stock	Buy	Acquire P	Yes	No	1.4466	6,517	9.43 k	629,090
6 Dec 24	Robin Shane Readnour	Common Stock	Buy	Acquire P	Yes	No	1.445	12,711	18.37 k	564,999
27 Nov 24	Zakrzewski Joseph S	Common Stock	Buy	Acquire P	No	No	1.4	2,000	2.80 k	125,199
27 Nov 24	Robin Shane Readnour	Common Stock	Buy	Acquire P	Yes	No	1.4167	25,000	35.42 k	622,573
27 Nov 24	Robin Shane Readnour	Common Stock	Buy	Acquire P	Yes	No	1.4169	25,000	35.42 k	552,288
26 Nov 24	Robin Shane Readnour	Common Stock	Buy	Acquire P	Yes	No	1.3942	12,500	17.43 k	597,573